J Thorac Cardiovasc Surg 2007;133:744-745
© 2007 The American Association for Thoracic Surgery
Discussion
| The first 20% of the full text of this article appears below. |
Dr Mark J. Krasna
(Baltimore, Md). First, I wish to congratulate Dr Meyers on an excellent presentation. Following up on the pioneering work at Washington University on PET scanning for thoracic malignancies, the ACSOG undertook two clinical trials to determine the role of PET scanning in our specialty. After presenting their findings from Z40 on PET scanning for lung cancer, the ACOSOG surgeons are now presenting the results of the first multi-institutional prospective phase 2 trial for PET scanning in esophageal cancer to put this new modality in perspective. All the surgeons who undertook this goal are to be congratulated for their completion of this trial. This in itself is a great accomplishment and is an example to us all to study questions in thoracic surgery thoroughly by clinical trial wherever possible.
The objective of this study was to see whether PET scan avoided unnecessary surgery in 5% or more of patients with esophageal cancer. The primary result of the study may be summarized as follows: PET scan identified suggestive . . . [Full Text of this Article]
Related Article
-
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial
- Bryan F. Meyers, Robert J. Downey, Paul A. Decker, Robert J. Keenan, Barry A. Siegel, Robert J. Cerfolio, Rodney J. Landreneau, Carolyn E. Reed, Dennis M. Balfe, Farrokh Dehdashti, Karla V. Ballman, Valerie W. Rusch, and Joe B. Putnam, Jr
J. Thorac. Cardiovasc. Surg. 2007 133: 738-745.
[Abstract]
[Full Text]
[PDF]
Copyright © 2007 by The American Association for Thoracic Surgery.